Concurrently, SLE is characterized by a breakdown in B‐cell tolerance, leading to the production of a broad spectrum of autoantibodies, including ANA, anti‐Sm, anti‐dsDNA, aPL, and anti‐β2GPI [10]. The gene discussed is BTG3; the disease is systemic lupus erythematosus.